X0508 4 2025-01-21 0001853816 Dermata Therapeutics, Inc. DRMA 0001024004 HALE DAVID F 3525 DEL MAR HEIGHTS RD. #322 SAN DIEGO CA 92130 true false false false false Common Stock 2025-01-23 4 A false 78741 A 80957 I By Hale BioPharma Ventures LLC Common Stock 314 D Common Stock 50 I By Hale Trading Company L.P. Common Stock 148 I By Hale Family Trust Warrant (Right to Buy) 1.27 2025-01-21 4 A false 78741 A Common Stock 78741 78741 I By Hale BioPharma Ventures LLC The shares of Common Stock and accompanying Warrant were purchased by the Reporting Person from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The purchase price per share of Common Stock and accompanying Warrant was $1.27. The Warrant will become exercisable beginning on the effective date of stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of the warrants. The Warrant will expire five years from the effective date of stockholder approval. The Warrant cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person, together with his/her affiliates, would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise, subject to certain exceptions. Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/ Gerald T. Proehl, Attorney-in-Fact 2025-01-23